AQR Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Buy |
141,773
+91,315
| +181% | +$313K | ﹤0.01% | 2623 |
|
|
2025
Q1 | $149K | Buy |
50,458
+39,641
| +366% | +$117K | ﹤0.01% | 2943 |
|
|
2024
Q4 | $33K | Buy |
+10,817
| New | +$33K | ﹤0.01% | 2832 |
|
|
2018
Q4 | – | Sell |
-29,911
| Closed | -$1.37M | – | 2251 |
|
|
2018
Q3 | $1.37M | Sell |
29,911
-14,912
| -33% | -$684K | ﹤0.01% | 1566 |
|
|
2018
Q2 | $2.65M | Buy |
44,823
+951
| +2% | +$56.2K | ﹤0.01% | 1294 |
|
|
2018
Q1 | $2.99M | Sell |
43,872
-1,349
| -3% | -$91.8K | ﹤0.01% | 1185 |
|
|
2017
Q4 | $4.47M | Sell |
45,221
-3,040
| -6% | -$300K | ﹤0.01% | 1074 |
|
|
2017
Q3 | $5.78M | Buy |
48,261
+30,056
| +165% | +$3.6M | 0.01% | 966 |
|
|
2017
Q2 | $1.59M | Buy |
+18,205
| New | +$1.59M | ﹤0.01% | 1483 |
|
|
2016
Q3 | – | Sell |
-13,410
| Closed | -$399K | – | 2281 |
|
|
2016
Q2 | $399K | Buy |
13,410
+3,513
| +35% | +$105K | ﹤0.01% | 1941 |
|
|
2016
Q1 | $291K | Buy |
9,897
+334
| +3% | +$9.82K | ﹤0.01% | 2005 |
|
|
2015
Q4 | $750K | Sell |
9,563
-11,678
| -55% | -$916K | ﹤0.01% | 1699 |
|
|
2015
Q3 | $1.6M | Sell |
21,241
-4,782
| -18% | -$360K | ﹤0.01% | 1232 |
|
|
2015
Q2 | $3.04M | Buy |
26,023
+9,272
| +55% | +$1.08M | 0.01% | 1007 |
|
|
2015
Q1 | $3.96M | Sell |
16,751
-1,200
| -7% | -$283K | 0.01% | 870 |
|
|
2014
Q4 | $3.4M | Buy |
17,951
+2,662
| +17% | +$504K | 0.01% | 1052 |
|
|
2014
Q3 | $3.65M | Sell |
15,289
-90,400
| -86% | -$21.6M | 0.01% | 967 |
|
|
2014
Q2 | $6.98M | Buy |
105,689
+68,300
| +183% | +$4.51M | 0.02% | 758 |
|
|
2014
Q1 | $3.89M | Sell |
37,389
-25,800
| -41% | -$2.69M | 0.01% | 955 |
|
|
2013
Q4 | $6.54M | Buy |
63,189
+1,373
| +2% | +$142K | 0.02% | 758 |
|
|
2013
Q3 | $3.32M | Buy |
61,816
+54,501
| +745% | +$2.92M | 0.01% | 995 |
|
|
2013
Q2 | $325K | Buy |
+7,315
| New | +$325K | ﹤0.01% | 2063 |
|